Diffuse Hepatic Fatty Cirrhosis

diffused hepatic fatty cirrhosis

Diffuse hepatic fatty cirrhosis is a potentially fatal liver disorder that may be misdiagnosed as viral hepatitis. The underlying cause of this disease is unknown, but several factors are believed to be responsible for its occurrence. The primary risk factors for the development of this condition include age, obesity, and infection. Despite these factors, there are certain diagnostic tests that can aid in the diagnosis of diffused hepatic fatty cirrhosis.

CT imaging may help diagnose the disease. Hepatic CT images can show the typical morphologic abnormalities associated with this condition. On CT, segmental hypertrophy affects the lateral and medial lobes, and a right posterior notch sign may be present. This liver disease can also be identified with a contrast-enhanced liver. Because the affected liver is receiving blood from the central vein, this condition can appear as a normal-looking hepatic image.

Diffuse hepatic fatty cirrhosis is a chronic liver disease that develops over time as a result of various pathophysiological processes. If left untreated, this disease progresses to full cirrhosis and is responsible for more than one million deaths each year. Fortunately, it is possible to detect diffused hepatic fatty cirrhosis in its early stages. Patients should undergo a diagnostic evaluation as soon as possible and monitor its progression during treatment. Currently, the gold standard for diagnosing this condition is a liver biopsy. However, this procedure is limited by the invasiveness, sampling error, and inter-observer variability.

In the absence of biopsy, this disease is often misdiagnosed as diffused hepatic fatty fibrosis. Imaging studies will show a variety of imaging findings, including diffuse hepatomegaly. On CT, focal areas of low attenuation in the liver correspond to the location of amyloid deposition. Patients may present with jaundice due to intrahepatic cholestasis.

Share this article: